RxSight (RXST) Net Income Growth (1y) (2021 - 2026)
RxSight (RXST) Net Income Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 99.11% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -30.10% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4,440.69% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 89.28% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | RxSight | 193.93 Mn | -23.95 Mn | 23.50 Mn | -93.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -93.94% |
| Dec 31, 2025 | -142.63% |
| Sep 30, 2025 | -54.88% |
| Jun 30, 2025 | -93.88% |
| Mar 31, 2025 | 10.00% |
| Dec 31, 2024 | -45.53% |
| Sep 30, 2024 | 48.95% |
| Jun 30, 2024 | 55.96% |
| Mar 31, 2024 | 31.12% |
| Dec 31, 2023 | -22.93% |
| Sep 30, 2023 | 26.18% |
| Jun 30, 2023 | 17.50% |
| Mar 31, 2023 | 24.91% |
| Dec 31, 2022 | 424.74% |
| Sep 30, 2022 | -32.71% |
| Jun 30, 2022 | -24.15% |
| Mar 31, 2022 | -158.57% |
| Dec 31, 2021 | -160.02% |
| Sep 30, 2021 | -141.33% |
| Jun 30, 2021 | -4.62% |